°µºÚ±¬ÁÏ

Pfizer recently announced plans to shut down its Boulder operations, but the life sciences industry is seeing the biopharmaceutical giant's departure as an opportunity.

The Colorado board’s choice of drugs to review elucidates one of the thorniest questions the board must wrangle with: Would lowering the price tag for rare-disease medications lead manufacturers to pull out of the state or limit their availability?

An experimental COVID-19 medicine that has been shown to shorten the time people with severe illness have to stay in the hospital finally has a price tag that's lower than some analysts expected.

His sentencing is the culmination of a months-long criminal trial that resulted in the first successful prosecution of pharmaceutical executives tied to the opioid epidemic.

John Kapoor, the former billionaire who founded drugmaker Insys Therapeutics, is among the executives to be sentenced for racketeering.

Updated Monday, November 18, 2019 to include a visualization of pharmacy closure in the Mountain West. A national study published in the journal JAMA…

Pharmaceutical companies are facing scrutiny over the opioid crisis, but that hasn’t stopped them from giving millions of dollars to members of Congress...

The pending settlement likely means Purdue will avoid going to trial in the sprawling and complicated case involving some 2,300 local governments across 23 states.

As addiction has soared, drugmakers, distributors and pharmacies profited off opioids. Newly released data details who made the pills, where they were sold, and which communities were hit hardest.

The deal to resolve all U.S. federal investigations and claims is the biggest drug industry settlement so far stemming from the nation's deadly opioid epidemic.